Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of a CHO cell-derived recombinant herpes zoster vaccine in adults aged 40 years and older
CTR20262854Phase 2Active
- Sponsor
- Janda Biotech
- Start
- Aug 2026
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant herpes zoster vaccine (CHO cells) in herpes zoster (HZ), sponsored by Janda Biotech. Started Aug 2026; status: active.
02
Drugs
recombinant herpes zoster vaccine (CHO cells)
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on CTR20262854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262854.